Pharmaceutical Technology on MSN9d
Taiho outlays $1.14bn to acquire ADC specialist ArarisTaiho Pharmaceutical has agreed to acquire Swiss-based antibody-drug-conjugate (ADC) specialist Araris Biotech for up to ...
The 4th World ADC Asia Summit is back, offering the most comprehensive platform for Asia’s rapidly growing ADC community.
This eBook explores the evolving ADC landscape, offering exclusive insights into clinical progress, regulatory approvals and ...
GlobalData on MSN2d
Innovent Biologics doses first subject in trial of ovarian cancer therapyInnovent Biologics has dosed the first subject in the Phase III HeriCare-Ovarian01 trial of IBI354 for treating PROC with ...
The application delivery controller (ADC) must be deployable anywhere they deploy applications ... and manage AI/ML apps and ...
Our goal is to enhance drug efficacy while minimizing ADC toxicity, offering transformative treatment alternatives for patients worldwide. Moreover, Akeso has established cutting-edge ADC research ...
Our goal is to enhance drug efficacy while minimizing ADC toxicity, offering transformative treatment alternatives for patients worldwide. Moreover, Akeso has established cutting-edge ADC research, ...
Alphamab Oncology (stock code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. ('CSPC') (Stock Code: 1093.HK) jointly announced that anti-HER2 biparatopic antibody-drug conjugate (ADC) JSKN003 has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback